Datasets:

Haxirus

/

Fine-Tuning_Dataset

like 0

Does Abciximab and Methyl salicylate interact?

.Concurrent use of salicylates and anticoagulants may lead to increased anticoagulant activity and therefore an increased risk of bleeding, due to additive anticoagulant effects. In short, The risk or severity of bleeding can be increased when Methyl salicylate is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Methylene blue interact?

It has been reported that concomitant administration of antiplatelet agents and monoamine oxidase inhibitor antidepressants that increase the levels of serotonin are associated with an increase in hemorrhage. This interaction is due to the inhibition of serotonin reuptake in platelets which produces a reduction of serotonin to even 1% of the normal quantity. Serotonin is very important for the aggregation of platelets and the lack of serotonin does not allow the normal aggregation process of the platelets. In short, The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Mifepristone interact?

Oral contraceptives may increase blood clotting factors and decrease the effectiveness of anticoagulants due to their prothrombotic effects.1,2,4 In contrast, in some patients anticoagulant effects may actually be potentiated by the use of oral contraceptives, although this risk appears to be relatively low. In short, The risk or severity of adverse effects can be increased when Mifepristone is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Milnacipran interact?

It has been reported that concomitant administration of antiplatelet agents and SSRI is associated with an increase in hemorrhage. This interaction is due to the inhibition of serotonin reuptake in platelets which produces a reduction of serotonin to even 1% of the normal quantity. Serotonin is very important for the aggregation of platelets and the lack of serotonin does not allow the normal aggregation process of the platelets. In short, The risk or severity of hemorrhage can be increased when Milnacipran is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Mirvetuximab soravtansine interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Mirvetuximab Soravtansine, and the severity of the interaction is minor.

Does Abciximab and Mitomycin interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Mitomycin, and the severity of the interaction is minor.

Does Abciximab and Mitoxantrone interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Mitoxantrone, and the severity of the interaction is minor.

Does Abciximab and Moclobemide interact?

It has been reported that concomitant administration of antiplatelet agents and monoamine oxidase inhibitor antidepressants that increase the levels of serotonin are associated with an increase in hemorrhage. This interaction is due to the inhibition of serotonin reuptake in platelets which produces a reduction of serotonin to even 1% of the normal quantity. Serotonin is very important for the aggregation of platelets and the lack of serotonin does not allow the normal aggregation process of the platelets. In short, The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Mogamulizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Mogamulizumab, and the severity of the interaction is minor.

Does Abciximab and Moroctocog alfa interact?

Blood coagulation factors promote the blood coagulation pathways to ultimately form the insoluble fibrin clot. In contrast, fibrinolytic agents activate the fibrinolytic system by conversion of the inactive proenzyme, plasminogen into the active enzyme plasmin, that degrades fibrin to break down the insoluble clot [A38173]. Desired procoagulant effects of blood coagulation factors may be reduced with the combination use of fibrinolytic agents. In short, The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Abciximab, and the severity of the interaction is major.

Does Abciximab and Mosunetuzumab interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Mosunetuzumab, and the severity of the interaction is minor.

Does Abciximab and Nabumetone interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Nadroparin interact?

Both antiplatelet agents and anticoagulants are associated with a risk of bleeding when administered alone. The concomitant use of these agents may further increase the risk for fatal and non-fatal bleeding events, including gastrointestinal hemorrhage. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Nadroparin, and the severity of the interaction is moderate.

Does Abciximab and Naproxen interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Natalizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Natalizumab, and the severity of the interaction is minor.

Does Abciximab and Necitumumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Necitumumab, and the severity of the interaction is minor.

Does Abciximab and Nefazodone interact?

It has been reported that concomitant administration of antiplatelet agents and SSRI is associated with an increase in hemorrhage. This interaction is due to the inhibition of serotonin reuptake in platelets which produces a reduction of serotonin to even 1% of the normal quantity. Serotonin is very important for the aggregation of platelets and the lack of serotonin does not allow the normal aggregation process of the platelets. In short, The risk or severity of hemorrhage can be increased when Nefazodone is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Nelarabine interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Nelarabine, and the severity of the interaction is minor.

Does Abciximab and Nilotinib interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Nilotinib, and the severity of the interaction is minor.

Does Abciximab and Nimesulide interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Nimesulide is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Nintedanib interact?

Nintedanib is an inhibitor of vascular endothelial growth factor receptor (VEGFR), a class of medications that have been shown to increase the risk of hemorrhagic events. Concomitant use of these agents with other anticoagulants may increase the risk of bleeding. In short, The risk or severity of bleeding can be increased when Nintedanib is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Nivolumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Nivolumab, and the severity of the interaction is minor.

Does Abciximab and Nomegestrol acetate interact?

Oral contraceptives may increase blood clotting factors and decrease the effectiveness of anticoagulants due to their prothrombotic effects.1,2,4 In contrast, in some patients anticoagulant effects may actually be potentiated by the use of oral contraceptives, although this risk appears to be relatively low. In short, The risk or severity of adverse effects can be increased when Nomegestrol acetate is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Nonacog beta pegol interact?

Blood coagulation factors promote the blood coagulation pathways to ultimately form the insoluble fibrin clot. In contrast, fibrinolytic agents activate the fibrinolytic system by conversion of the inactive proenzyme, plasminogen into the active enzyme plasmin, that degrades fibrin to break down the insoluble clot [A38173]. Desired procoagulant effects of blood coagulation factors may be reduced with the combination use of fibrinolytic agents. In short, The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Abciximab, and the severity of the interaction is major.

Does Abciximab and Norethisterone interact?

Oral contraceptives may increase blood clotting factors and decrease the effectiveness of anticoagulants due to their prothrombotic effects.1,2,4 In contrast, in some patients anticoagulant effects may actually be potentiated by the use of oral contraceptives, although this risk appears to be relatively low. In short, The risk or severity of adverse effects can be increased when Norethisterone is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Norgestrel interact?

Oral contraceptives may increase blood clotting factors and decrease the effectiveness of anticoagulants due to their prothrombotic effects.1,2,4 In contrast, in some patients anticoagulant effects may actually be potentiated by the use of oral contraceptives, although this risk appears to be relatively low. In short, The risk or severity of adverse effects can be increased when Norgestrel is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Obeticholic acid interact?

Antiplatelet agents may enhance the bleeding risk when administered with cholic acid due to the additive effects of both drugs. In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Obeticholic acid, and the severity of the interaction is moderate.

Does Abciximab and Obiltoxaximab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Obiltoxaximab, and the severity of the interaction is minor.

Does Abciximab and Obinutuzumab interact?

Obinutuzumab has the potential to cause thrombocytopenia.1 When combined with antiplatelet agents, the risk of bleeding from obinutuzumab is increased. In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Obinutuzumab, and the severity of the interaction is moderate.

Does Abciximab and Ocrelizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Ocrelizumab, and the severity of the interaction is minor.

Does Abciximab and Ofatumumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Ofatumumab, and the severity of the interaction is minor.

Does Abciximab and Olaparib interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Olaparib, and the severity of the interaction is minor.

Does Abciximab and Olaratumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Olaratumab, and the severity of the interaction is minor.

Does Abciximab and Olive oil interact?

Olive oil has high vitamin K1 contents.1 Vitamin K1 serves as a vitamin required for blood coagulation,2 and may counteract the anticoagulant activity of vitamin K antagonists such as warfarin. However, there were no drug-interaction studies that examined the effect of soybean on the therapeutic efficacy of anticoagulant drugs. In short, The therapeutic efficacy of Abciximab can be decreased when used in combination with Olive oil, and the severity of the interaction is minor.

Does Abciximab and Olsalazine interact?

.Concurrent use of salicylates and anticoagulants may lead to increased anticoagulant activity and therefore an increased risk of bleeding, due to additive anticoagulant effects. In short, The risk or severity of bleeding can be increased when Olsalazine is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Omacetaxine mepesuccinate interact?

Omacetaxine mepesuccinate therapy has been associated with drug-induced thrombocytopenia that may lead to bleeding events. Co-administration of omacetaxine mepesuccinate with drugs affecting hemostasis, including anticoagulants, may significantly increase the risk for bleeding and hemorrhage. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Omacetaxine mepesuccinate, and the severity of the interaction is moderate.

Does Abciximab and Omalizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Omalizumab is combined with Abciximab, and the severity of the interaction is minor.

Does Abciximab and Omega-3 fatty acids interact?

In vitro, fish oils containing omega-3 fatty acid competitively inhibit cyclo-oxygenase which decreases synthesis of thromboxane A2 from arachidonic acid (ARA) in platelets. The cyclo-oxygenase mediated generation of thromboxane A2 from ARA in platelets plays a vital role in blood coagulation. The concurrent administration of omega-3 fatty acids with antiplatelets may potentiate the bleeding risk normally associated with antiplatelet agents. In short, Omega-3 fatty acids may increase the antiplatelet activities of Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Omega-3-acid ethyl esters interact?

Prolonged bleeding time was seen in some trials however formal clinical trials to determine the effect of omega-3-acid ethyl esters on anticoagulants have yet to be performed. In short, The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Abciximab, and the severity of the interaction is minor.

Does Abciximab and Oxaliplatin interact?

In clinical trials, the incidence of hemorrhage was higher in patients taking oxaliplatin with fluorouracil/leucovorin. Therefore, the co-administration of oxaliplatin and anticoagulants can further increase the risk of hemorrhage. Particularly, prolonged prothrombin time and INR have been reported in patients receiving oxaliplatin with fluorouracil/leucovorin combination while also on anticoagulants. In short, The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Oxaprozin interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Paclitaxel interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Paclitaxel, and the severity of the interaction is minor.

Does Abciximab and Padeliporfin interact?

Padeliporfin is a drug used in Vascular-Targeted Photodynamic therapy procedures. Patients with abnormal clotting may bleed excessively from the insertion of the needles required to position the fibres that guide the laser light. This may also cause bruising, blood in the urine and/or local pain. Abnormal clotting is not expected to affect how well the treatment works; however, it is recommended that drugs that affect clotting are stopped prior to and for the immediate period following the Vascular-Targeted Photodynamic therapy procedure. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Padeliporfin, and the severity of the interaction is moderate.

Does Abciximab and Palbociclib interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Palbociclib, and the severity of the interaction is minor.

Does Abciximab and Palivizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Palivizumab, and the severity of the interaction is minor.

Does Abciximab and Panitumumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Panitumumab, and the severity of the interaction is minor.

Does Abciximab and Pantothenic acid interact?

Blood coagulation factors promote the blood coagulation pathways to ultimately form the insoluble fibrin clot. In contrast, fibrinolytic agents activate the fibrinolytic system by conversion of the inactive proenzyme, plasminogen into the active enzyme plasmin, that degrades fibrin to break down the insoluble clot [A38173]. Desired procoagulant effects of blood coagulation factors may be reduced with the combination use of fibrinolytic agents. In short, The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Abciximab, and the severity of the interaction is major.

Does Abciximab and Parecoxib interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Parnaparin interact?

Both antiplatelet agents and anticoagulants are associated with a risk of bleeding when administered alone. The concomitant use of these agents may further increase the risk for fatal and non-fatal bleeding events, including gastrointestinal hemorrhage. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Parnaparin, and the severity of the interaction is moderate.

Does Abciximab and Paroxetine interact?

It has been reported that concomitant administration of antiplatelet agents and SSRI is associated with an increase in hemorrhage. This interaction is due to the inhibition of serotonin reuptake in platelets which produces a reduction of serotonin to even 1% of the normal quantity. Serotonin is very important for the aggregation of platelets and the lack of serotonin does not allow the normal aggregation process of the platelets. In short, The risk or severity of hemorrhage can be increased when Paroxetine is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Peginterferon alfa-2a interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa-2a, and the severity of the interaction is minor.

Does Abciximab and Peginterferon alfa-2b interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa-2b, and the severity of the interaction is minor.

Does Abciximab and Peginterferon beta-1a interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon beta-1a, and the severity of the interaction is minor.

Does Abciximab and Pembrolizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Pembrolizumab, and the severity of the interaction is minor.

Does Abciximab and Pemetrexed interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Pemetrexed, and the severity of the interaction is minor.

Does Abciximab and Penicillamine interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Penicillamine, and the severity of the interaction is minor.

Does Abciximab and Pentosan polysulfate interact?

Pentosan polysulfate sodium itself is a weak blood thinner and has demonstrated to be associated with bleeding complications such as rectal hemorrhage, bruising, nosebleeds, and gum bleeding. Therefore, when taken with antiplatelet agents, bleeding risk is enhanced due to additive drug effects. In short, The risk or severity of adverse effects can be increased when Pentosan polysulfate is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Pentostatin interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Pentostatin, and the severity of the interaction is minor.

Does Abciximab and Pentoxifylline interact?

There have been reports of bleeding or prolonged prothrombin time in patients treated with pentoxifylline even without anticoagulant treatment. The risk of bleeding is further increased when anticoagulants are administered. Some studies report a lack of pharmacodynamic effect resulting from this interaction, however, caution is nonetheless advised. In short, The therapeutic efficacy of Abciximab can be increased when used in combination with Pentoxifylline, and the severity of the interaction is moderate.

Does Abciximab and Pertuzumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Pertuzumab, and the severity of the interaction is minor.

Does Abciximab and Phenelzine interact?

It has been reported that concomitant administration of antiplatelet agents and monoamine oxidase inhibitor antidepressants that increase the levels of serotonin are associated with an increase in hemorrhage. This interaction is due to the inhibition of serotonin reuptake in platelets which produces a reduction of serotonin to even 1% of the normal quantity. Serotonin is very important for the aggregation of platelets and the lack of serotonin does not allow the normal aggregation process of the platelets. In short, The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Phenprocoumon interact?

Both antiplatelet agents and anticoagulants are associated with a risk of bleeding when administered alone. The concomitant use of these agents may further increase the risk for fatal and non-fatal bleeding events, including gastrointestinal hemorrhage. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Phenprocoumon, and the severity of the interaction is moderate.

Does Abciximab and Phenylalanine interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Phenylalanine, and the severity of the interaction is minor.

Does Abciximab and Piroxicam interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Pirtobrutinib interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Pirtobrutinib, and the severity of the interaction is minor.

Does Abciximab and Polatuzumab vedotin interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Polatuzumab vedotin, and the severity of the interaction is minor.

Does Abciximab and Polythiazide interact?

The efficacy of oral anticoagulants may be reduced by the concomitant use of thiazide diuretics.2 The evidence for this interaction is conflicting.1 In short, The therapeutic efficacy of Abciximab can be decreased when used in combination with Polythiazide, and the severity of the interaction is minor.

Does Abciximab and Pomalidomide interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Pomalidomide, and the severity of the interaction is minor.

Does Abciximab and Ponatinib interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Ponatinib, and the severity of the interaction is minor.

Does Abciximab and Potassium Iodide interact?

Due to potential inhibition of vitamin K activity by methimazole and other antithyroid agents, the activity of anticoagulants (for example, warfarin) may be increased. The activity of oral anticoagulants may be potentiated by anti-vitamin-K activity attributed to methimazole and other antithyroid medications. In short, Potassium Iodide may increase the anticoagulant activities of Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Pozelimab interact?

Since pozelimab is an IgG4 antibody, co-administration of pozelimab with other immunoglobulins-based products can interfere with the endosomal neonatal Fc receptor (FcRn) recycling mechanism of monoclonal antibodies, thus decreasing the serum concentration of pozelimab. In short, The serum concentration of Pozelimab can be decreased when it is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Prasugrel interact?

Both antiplatelet agents and anticoagulants are associated with a risk of bleeding when administered alone. The concomitant use of these agents may further increase the risk for fatal and non-fatal bleeding events, including gastrointestinal hemorrhage. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Prasugrel, and the severity of the interaction is moderate.

Does Abciximab and Procaine interact?

It has been reported that concomitant administration of antiplatelet agents and monoamine oxidase inhibitor antidepressants that increase the levels of serotonin are associated with an increase in hemorrhage. This interaction is due to the inhibition of serotonin reuptake in platelets which produces a reduction of serotonin to even 1% of the normal quantity. Serotonin is very important for the aggregation of platelets and the lack of serotonin does not allow the normal aggregation process of the platelets. In short, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Procarbazine interact?

It has been reported that concomitant administration of antiplatelet agents and monoamine oxidase inhibitor antidepressants that increase the levels of serotonin are associated with an increase in hemorrhage. This interaction is due to the inhibition of serotonin reuptake in platelets which produces a reduction of serotonin to even 1% of the normal quantity. Serotonin is very important for the aggregation of platelets and the lack of serotonin does not allow the normal aggregation process of the platelets. In short, The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Progesterone interact?

Systemic hormonal contraceptives, such as the subject drug, are known to increase the risk of venous thromboembolism (VTE).4,1,3 While specific data regarding the concomitant use of hormonal contraceptives and anticoagulants is sparse, it follows that the procoagulant effects of hormonal contraceptives may oppose the therapeutic effects of anticoagulants, lowering their efficacy and increasing the risk of clotting. The estrogen component of combined hormonal contraceptives appears to the be the primary culprit in their induction of hypercoagulability - its effects appear to be driven by alterations to procoagulant proteins (i.e. clotting factors) and an induced resistance to activated protein C (APC), an endogenous anticoagulant. While it was previously thought that first-pass metabolism of oral contraceptives through the liver was responsible for their prothrombotic effect, more recent studies have suggested that alternative routes of administration (i.e. routes that bypass first-pass metabolism) do not improve the risk of clotting, and this is reflected in the FDA labeling for these non-oral contraceptive options. Progestin-only contraceptives do not appear to carry the same risk of thrombotic events as do estrogen-containing contraceptives. This interaction is likely to be more significant in patients with other risk factors for hormonal contraceptive-induced thrombotic events, such as smoking, age >35, obesity, and hypertension. In short, The therapeutic efficacy of Abciximab can be decreased when used in combination with Progesterone, and the severity of the interaction is moderate.

Does Abciximab and Propylthiouracil interact?

Due to potential inhibition of vitamin K activity by methimazole and other antithyroid agents, the activity of anticoagulants (for example, warfarin) may be increased. The activity of oral anticoagulants may be potentiated by anti-vitamin-K activity attributed to methimazole and other antithyroid medications. In short, Propylthiouracil may increase the anticoagulant activities of Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Protein C interact?

Both antiplatelet agents and anticoagulants are associated with a risk of bleeding when administered alone. The concomitant use of these agents may further increase the risk for fatal and non-fatal bleeding events, including gastrointestinal hemorrhage. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Protein C, and the severity of the interaction is moderate.

Does Abciximab and Quinidine interact?

Quinine has the potential to depress hepatic enzyme synthesis of vitamin K-dependent coagulation pathway proteins and thus, it can enhance the action of other anticoagulants. In short, The therapeutic efficacy of Abciximab can be increased when used in combination with Quinidine, and the severity of the interaction is moderate.

Does Abciximab and Quinine interact?

Quinine has the potential to depress hepatic enzyme synthesis of vitamin K-dependent coagulation pathway proteins and thus, it can enhance the action of other anticoagulants. In short, The therapeutic efficacy of Abciximab can be increased when used in combination with Quinine, and the severity of the interaction is moderate.

Does Abciximab and Raltitrexed interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Raltitrexed, and the severity of the interaction is minor.

Does Abciximab and Ramucirumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Ramucirumab, and the severity of the interaction is minor.

Does Abciximab and Ranibizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Ranibizumab, and the severity of the interaction is minor.

Does Abciximab and Rasagiline interact?

It has been reported that concomitant administration of antiplatelet agents and monoamine oxidase inhibitor antidepressants that increase the levels of serotonin are associated with an increase in hemorrhage. This interaction is due to the inhibition of serotonin reuptake in platelets which produces a reduction of serotonin to even 1% of the normal quantity. Serotonin is very important for the aggregation of platelets and the lack of serotonin does not allow the normal aggregation process of the platelets. In short, The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Ravulizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Ravulizumab, and the severity of the interaction is minor.

Does Abciximab and Raxibacumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Raxibacumab, and the severity of the interaction is minor.

Does Abciximab and Reslizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Reslizumab, and the severity of the interaction is minor.

Does Abciximab and Reteplase interact?

Both antiplatelet agents and anticoagulants are associated with a risk of bleeding when administered alone. The concomitant use of these agents may further increase the risk for fatal and non-fatal bleeding events, including gastrointestinal hemorrhage. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Reteplase, and the severity of the interaction is moderate.

Does Abciximab and Risankizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Risankizumab, and the severity of the interaction is minor.

Does Abciximab and Rituximab interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Rituximab, and the severity of the interaction is minor.

Does Abciximab and Rivaroxaban interact?

Concomitant use of rivaroxaban with drugs affecting hemostasis, including other anticoagulants, leads to an additive effect on anti-factor Xa activity of ribaroxavan and increases the risk of bleeding. In short, Abciximab may increase the anticoagulant activities of Rivaroxaban, and the severity of the interaction is major.

Does Abciximab and Romosozumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Romosozumab, and the severity of the interaction is minor.

Does Abciximab and Ropeginterferon alfa-2b interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Ropeginterferon alfa-2b, and the severity of the interaction is minor.

Does Abciximab and Rozanolixizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Rozanolixizumab, and the severity of the interaction is minor.

Does Abciximab and Rurioctocog alfa pegol interact?

Blood coagulation factors promote the blood coagulation pathways to ultimately form the insoluble fibrin clot. In contrast, fibrinolytic agents activate the fibrinolytic system by conversion of the inactive proenzyme, plasminogen into the active enzyme plasmin, that degrades fibrin to break down the insoluble clot [A38173]. Desired procoagulant effects of blood coagulation factors may be reduced with the combination use of fibrinolytic agents. In short, The therapeutic efficacy of Rurioctocog alfa pegol can be decreased when used in combination with Abciximab, and the severity of the interaction is major.

Does Abciximab and Ruxolitinib interact?

As their name suggested, myelosuppressive agents can decrease the production of cells found in the bone marrow, including thrombocytes.5,1 Low levels of thrombocytes, or thrombocytopenia, can increase the risk of bleeding due to the inability to form blood clots. Therefore, concomitant administration of agents that prevent thrombotic events such as antiplatelet agents can further exacerbate this risk into abnormal bleeding. In short, The risk or severity of bleeding can be increased when Abciximab is combined with Ruxolitinib, and the severity of the interaction is minor.

Does Abciximab and Sacituzumab govitecan interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Sacituzumab govitecan, and the severity of the interaction is minor.

Does Abciximab and Safinamide interact?

It has been reported that concomitant administration of antiplatelet agents and monoamine oxidase inhibitor antidepressants that increase the levels of serotonin are associated with an increase in hemorrhage. This interaction is due to the inhibition of serotonin reuptake in platelets which produces a reduction of serotonin to even 1% of the normal quantity. Serotonin is very important for the aggregation of platelets and the lack of serotonin does not allow the normal aggregation process of the platelets. In short, The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Salicylic acid interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Salsalate interact?

Both anticoagulants and non-steroidal anti-inflammatory agents are associated with a risk for bleeding events. Concomitant use of anticoagulants with over-the-counter NSAIDs may significantly increase the risk for gastrointestinal hemorrhage while concomitant use of anticoagulants with acetaminophen may lead to increased risk for general all-site bleeding events. NSAIDs such as ibuprofen are substrates of CYP2C9, which may also interfere with the metabolism of S-warfarin and further increase the risk for warfarin-associated bleeding. In short, The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Abciximab, and the severity of the interaction is moderate.

Does Abciximab and Sarilumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Abciximab is combined with Sarilumab, and the severity of the interaction is minor.